Switzerland· 69569002
Voxzogo 0.56 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
A vosoritide product containing vosoritidum, registered in Switzerland by DRAC AG and dispensed under Swissmedic category A. The same ATC class is registered in 10 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Vosoritide is registered in 10 of 19 countries.
Countries holding a registration under ATC M05BX07 (vosoritide), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Vosoritide · ATC M05BX07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- vosoritidum
- Manufacturer
- DRAC AG
- Country
- Switzerland (CH)
- ATC code
- M05BX07
- ATC class
- Vosoritide
- Defined daily dose
- 0.4 mg, P
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vosoritide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVoxzogo 0.56 mgBioMarin International
- SpainVOXZOGO 0,56 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBiomarin International Limited
- IcelandVoxzogoBioMarin International Limited
- PolandVoxzogoBioMarin International Ltd.
- SwedenVoxzogo 0,56 mg Pulver och vätska till injektionsvätska, lösningBioMarin International Limited
- NetherlandsVoxzogo 0,4 mg, poeder en oplosmiddel voor oplossing voor injectieBioMarin International Limited
- CzechiaVOXZOGOBioMarin International Limited, Dublin
- FinlandVoxzogoBiomarin International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voxzogo
- Liechtenstein · Voxzogo
- Norway · Voxzogo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e06f4425-58b8-47fa-85a5-bf6d04266e11 GET /v1/drugs/e06f4425-58b8-47fa-85a5-bf6d04266e11?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Biotechnologika"
}See everything about vosoritide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.